81
52
Growth Score 81 in past quarter
-8 pts
Heat Score 52 in past quarter
-12 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
969027
Antagene is a biotechnology company which develops and sells DNA tests witin the framework of animal health, veterinary diagnosis.
- Delphine Delattre: Co-Founder, Executive Director & General Manager
- Guillaume Queney: Co-Founder & President
About the Company
ANTAGENE is a biotechnology company which develops and sells DNA tests witin the framework of animal health, tracability and veterinary diagnosis. ANTAGENE is the expert of the detection of genetic diseases and the genetic identification in dog and cat. ANTAGENE aims at developing and selling a full range of DNA tests to detect the most gravous
genetic diseases for dogs and cats health and wellness. Thanks to these DNA tests breeder prematurely select the breeding animals and then avoid breeding puppies or kittens suffering from an incapaciting disease. The generalization of this early detection will enable to limit the spread of the genetic anomaly in breedings and the breed.
